Epsilon M&A Deal Report - Quintiles Transnational
Transaction Multiples for the Valuation of Private Companies
Pharma Services Holding / Quintiles Transnational
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
Current | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 130
Date | Acquirer | Target | Country | Multiples | See details |
22/12/2008 | ReSearch Pharmaceutical Services | Therapharm Recherches | France | ** | 19637 |
02/01/2009 | Atrium Innovations | EAB Enzym-Arzneimittel-Berlin | Germany | * | 19636 |
Source: Epsilon Research / EMAT